Skandinaviska Enskilda Banken AB publ lifted its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 2.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 76,239 shares of the financial services provider’s stock after acquiring an additional 2,097 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in CME Group were worth $21,011,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Webster Bank N. A. increased its holdings in CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 60 shares during the period. Highline Wealth Partners LLC lifted its stake in CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 43 shares during the last quarter. Trifecta Capital Advisors LLC grew its holdings in CME Group by 59.2% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after acquiring an additional 42 shares in the last quarter. Ransom Advisory Ltd purchased a new stake in shares of CME Group in the 1st quarter valued at approximately $31,000. Finally, Westside Investment Management Inc. raised its holdings in shares of CME Group by 105.0% in the 2nd quarter. Westside Investment Management Inc. now owns 123 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 63 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Stock Up 0.2%
Shares of CME Group stock opened at $281.50 on Friday. CME Group Inc. has a one year low of $224.62 and a one year high of $290.79. The company has a market cap of $101.51 billion, a P/E ratio of 27.28, a PEG ratio of 4.41 and a beta of 0.38. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a fifty day moving average of $270.60 and a two-hundred day moving average of $272.71.
CME Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be issued a $1.25 dividend. The ex-dividend date of this dividend is Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. CME Group’s dividend payout ratio (DPR) is 48.45%.
Wall Street Analysts Forecast Growth
CME has been the subject of a number of recent analyst reports. Raymond James Financial decreased their price target on CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a report on Monday, October 13th. Barclays decreased their target price on CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 8th. Morgan Stanley increased their price target on shares of CME Group from $312.00 to $314.00 and gave the company an “overweight” rating in a research note on Thursday, October 23rd. UBS Group reduced their price objective on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a research report on Thursday, October 23rd. Finally, Piper Sandler increased their target price on shares of CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Eight analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, CME Group has a consensus rating of “Hold” and a consensus target price of $287.71.
Check Out Our Latest Analysis on CME Group
Insider Activity at CME Group
In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of the stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the transaction, the director owned 1,091 shares in the company, valued at $287,511.23. This trade represents a 47.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares of the company’s stock, valued at $2,056,962. This trade represents a 4.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 2,147 shares of company stock valued at $562,079 over the last 90 days. Company insiders own 0.30% of the company’s stock.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- MarketBeat Week in Review – 11/24 – 11/28
- What Makes a Stock a Good Dividend Stock?
- Power On: Applied Digital’s First AI Data Center Goes Live
- 3 Stocks to Consider Buying in October
- Alphabet: The AI Leader Best Positioned to Dominate 2026
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
